Company intelligence / Profile preview

Yiming Biopharmaceutical Technology

Hangzhou, Zhejiang, China

Ownership: Private
Employees: ~50
Development stage: Other

Overview

Yiming Biopharmaceutical Technology is a clinical-stage biotechnology company headquartered in Hangzhou, China, specializing in the discovery and development of targeted protein degradation (TPD) therapies. The company utilizes its proprietary Glue-Engine platform to design high-potency molecular glues and PROTACs targeting previously undruggable proteins involved in cancer and other serious diseases. Its lead candidate, YM001, is a molecular glue degrader targeting GSPT1 currently undergoing Phase 1 clinical trials for the treatment of advanced solid tumors. Founded by former Pfizer executive Dr. Yuan-Hua Ding, the company is backed by top-tier life science investors including Lilly Asia Ventures and Qiming Venture Partners.

Therapeutic areas: HematologyOncology
Modalities: Small moleculeMolecular glue therapyProteolysis-targeting chimera therapy
Industry: Biotech

Beyond the preview

Go deeper on Yiming Biopharmaceutical Technology.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Yiming Biopharmaceutical Technology.

Explore the full profile